Latest Capital Raises News

Excite Technology Services reported a strong 53% revenue increase to $12.27 million for FY2025 but also saw its net loss nearly double to $4.44 million. The company expanded its footprint with the acquisition of digital forensics specialist CBIT Pty Ltd.

Nanoveu Limited has successfully completed the second tranche of its upsized capital raise, securing $720,000 through share issuance and listed options, with a final $400,000 tranche pending shareholder approval.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Mount Hope Mining Limited has announced a non-renounceable pro-rata Loyalty Option Offer to raise approximately $103,125, aiming to bolster exploration funding and reward shareholder loyalty.

RTG Mining has completed a A$15.3 million tranche 2 placement, bolstering its financial position to advance the Mabilo gold and copper project and explore new opportunities.

Tamboran Resources has successfully closed the first tranche of its PIPE, raising US$38.7 million to advance its Beetaloo Basin projects, with a second tranche pending shareholder approval.

Horizon Minerals has acknowledged an unintentional breach of ASX Listing Rule 15.7 after sharing details of a $30 million placement with the media before the official market announcement.

Wingara AG Limited reported an 18% revenue increase to $3.5 million for FY25 but posted a reduced net loss of $1.47 million, reflecting a strategic pause in fodder operations amid challenging market conditions.

Flagship Minerals has raised A$1.25 million through a share placement and convertible note conversions to advance the Pantanillo Gold Project towards a JORC-compliant resource. The funds will support drilling, metallurgical testing, and environmental studies aimed at unlocking the project’s significant gold inventory.

Askari Metals has reported partial uptake in its recent entitlement offer for new options, raising about half of the targeted funds, with plans underway to complete the shortfall. The move supports ongoing exploration projects in lithium and uranium.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

Cardiex Limited has raised $2.4 million through an institutional placement and launched a fully underwritten entitlement offer to raise up to $4.1 million, aiming to scale its CONNEQT Pulse device.